Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008

go back to reference Coons SJ: Health-related quality of life: let's measure and report it appropriately. Clinical Therapeutics 2007, 29: 2746–2747. 10.1016/j.clinthera.2007.12.031PubMedCrossRef Coons SJ: Health-related quality of life: let's measure and report it appropriately. Clinical Therapeutics 2007, 29: 2746–2747. 10.1016/j.clinthera.2007.12.031PubMedCrossRef

go back to reference Montazeri A, Milroy R, Hole D, McEwen J, Gillis CR: How quality of life data contribute to our understanding of cancer patients' experiences? A study of patients with lung cancer. Qual Life Res 2003, 12: 157–166. 10.1023/A:1022232624891PubMedCrossRef Montazeri A, Milroy R, Hole D, McEwen J, Gillis CR: How quality of life data contribute to our understanding of cancer patients' experiences? A study of patients with lung cancer. Qual Life Res 2003, 12: 157–166. 10.1023/A:1022232624891PubMedCrossRef

go back to reference Montazeri A: Health-related quality of life in breast cancer patients: a bibliographic of the literature from 1974 to 2007. J Exp Clin Cancer Res 2008, 27: 32. 10.1186/1756-9966-27-32PubMedPubMedCentralCrossRef Montazeri A: Health-related quality of life in breast cancer patients: a bibliographic of the literature from 1974 to 2007. J Exp Clin Cancer Res 2008, 27: 32. 10.1186/1756-9966-27-32PubMedPubMedCentralCrossRef

go back to reference Trask PC, Hsu MA, McQuellon R: Other paradigms: health-related quality of life as a measure in cancer treatment: its importance and relevance. Cancer J 2009, 15: 435–440. 10.1097/PPO.0b013e3181b9c5b9PubMedCrossRef Trask PC, Hsu MA, McQuellon R: Other paradigms: health-related quality of life as a measure in cancer treatment: its importance and relevance. Cancer J 2009, 15: 435–440. 10.1097/PPO.0b013e3181b9c5b9PubMedCrossRef

go back to reference Quinten C, Coens C, Mauer M, Comte S, Sprangers MA, Cleeland C, Osoba D, Bjordal K, Bottomley A, EORTC Clinical Groups: Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol 2009, 10: 865–871. 10.1016/S1470-2045(09)70200-1PubMedCrossRef Quinten C, Coens C, Mauer M, Comte S, Sprangers MA, Cleeland C, Osoba D, Bjordal K, Bottomley A, EORTC Clinical Groups: Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol 2009, 10: 865–871. 10.1016/S1470-2045(09)70200-1PubMedCrossRef

go back to reference Grande GE, Farquhar MC, Barclay SI, Todd CJ: Quality of life measures (EORTC QLQ-C30 and SF-36) as predictors of survival in palliative colorectal and lung cancer patients. Palliat Support Care 2009, 7: 289–297. 10.1017/S1478951509990216PubMedCrossRef Grande GE, Farquhar MC, Barclay SI, Todd CJ: Quality of life measures (EORTC QLQ-C30 and SF-36) as predictors of survival in palliative colorectal and lung cancer patients. Palliat Support Care 2009, 7: 289–297. 10.1017/S1478951509990216PubMedCrossRef

go back to reference van Heijl M, Sprangers MA, de Boer AG, Lagarde SM, Reitsma HB, Busch OR, Tilanus HW, van Lanschot JJ, van Berge Henegouwen MI: Preoperative and early postoperative quality of life predict survival in potentially curable patients with esophageal cancer. Ann Surg Oncol, in press. van Heijl M, Sprangers MA, de Boer AG, Lagarde SM, Reitsma HB, Busch OR, Tilanus HW, van Lanschot JJ, van Berge Henegouwen MI: Preoperative and early postoperative quality of life predict survival in potentially curable patients with esophageal cancer. Ann Surg Oncol, in press.

go back to reference US Food and Drug Administration: Guidance for industry on patient-reported outcome measures: use in medical product development to support labeling claims. [http://www.fda.gov/ohrms/dockets/dockets/06d0044/06d0044.htm] US Food and Drug Administration: Guidance for industry on patient-reported outcome measures: use in medical product development to support labeling claims. [http://​www.​fda.​gov/​ohrms/​dockets/​dockets/​06d0044/​06d0044.​htm]

go back to reference Efficace F, Kemmler G, Vignetti M, Mandelli F, Molica S, Holzner B: Health-related quality of life assessment and reported outcomes in leukaemia randomized controlled trials: a systematic review to evaluate the added value in supporting clinical decision making. Eur J Cancer 2008, 44: 1497–1506. 10.1016/j.ejca.2008.03.017PubMedCrossRef Efficace F, Kemmler G, Vignetti M, Mandelli F, Molica S, Holzner B: Health-related quality of life assessment and reported outcomes in leukaemia randomized controlled trials: a systematic review to evaluate the added value in supporting clinical decision making. Eur J Cancer 2008, 44: 1497–1506. 10.1016/j.ejca.2008.03.017PubMedCrossRef

go back to reference Efficace F, Vignetti M, Mandelli F: Asking patients with hematological malignancies: 'how do you fee?' Does it really provide independent prognostic information for survival? Eur J Haematol 2009, 82: 484–485. 10.1111/j.1600-0609.2009.01254.xPubMedCrossRef Efficace F, Vignetti M, Mandelli F: Asking patients with hematological malignancies: 'how do you fee?' Does it really provide independent prognostic information for survival? Eur J Haematol 2009, 82: 484–485. 10.1111/j.1600-0609.2009.01254.xPubMedCrossRef

go back to reference Pater JL, Loeb M: Non-anatomic prognostic factors in carcinoma of the lung: a multivariate analysis. Cancer 1982, 50: 326–331. 10.1002/1097-0142(19820715)50:2<326::AID-CNCR2820500227>3.0.CO;2-GPubMedCrossRef Pater JL, Loeb M: Non-anatomic prognostic factors in carcinoma of the lung: a multivariate analysis. Cancer 1982, 50: 326–331. 10.1002/1097-0142(19820715)50:2<326::AID-CNCR2820500227>3.0.CO;2-GPubMedCrossRef

go back to reference Cassileth BR, Lusk EJ, Miller DS, Brown LL, Miller C: Psychosocial correlates of survival in advanced malignant disease? N Engl J Med 1985, 312: 1551–555. 10.1056/NEJM198506133122406PubMedCrossRef Cassileth BR, Lusk EJ, Miller DS, Brown LL, Miller C: Psychosocial correlates of survival in advanced malignant disease? N Engl J Med 1985, 312: 1551–555. 10.1056/NEJM198506133122406PubMedCrossRef

go back to reference Coates A, Gebski V, Bishop JF, Jeal PN, Woods RL, Snyder R, Tattersall MH, Byrne M, Harvey V, Gill G: Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategy. N Engl J Med 1987, 317: 1490–1495. 10.1056/NEJM198712103172402PubMedCrossRef Coates A, Gebski V, Bishop JF, Jeal PN, Woods RL, Snyder R, Tattersall MH, Byrne M, Harvey V, Gill G: Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategy. N Engl J Med 1987, 317: 1490–1495. 10.1056/NEJM198712103172402PubMedCrossRef

go back to reference Kaasa S, Mastekaasa A, Lund E: Prognostic factors for patients with inoperable non-small cell lung cancer, limited disease. The importance of patients' subjective experience of disease and psychosocial well-being. Radiother Oncol 1989, 15: 235–242. 10.1016/0167-8140(89)90091-1PubMedCrossRef Kaasa S, Mastekaasa A, Lund E: Prognostic factors for patients with inoperable non-small cell lung cancer, limited disease. The importance of patients' subjective experience of disease and psychosocial well-being. Radiother Oncol 1989, 15: 235–242. 10.1016/0167-8140(89)90091-1PubMedCrossRef

go back to reference Degner L, Sloan J: Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancer. J Pain Symptom Manage 1995, 10: 423–431. 10.1016/0885-3924(95)00056-5PubMedCrossRef Degner L, Sloan J: Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancer. J Pain Symptom Manage 1995, 10: 423–431. 10.1016/0885-3924(95)00056-5PubMedCrossRef

go back to reference Ringdal GI, Götestam KG, Kaasa S, Kvinnsland S, Ringdal K: Prognostic factors and survival in a heterogeneous sample of cancer patients. Br J Cancer 1996, 73: 1594–1599.PubMedPubMedCentralCrossRef Ringdal GI, Götestam KG, Kaasa S, Kvinnsland S, Ringdal K: Prognostic factors and survival in a heterogeneous sample of cancer patients. Br J Cancer 1996, 73: 1594–1599.PubMedPubMedCentralCrossRef

go back to reference Tamburini M, Brunelli C, Rosso S, Ventafridda V: Prognostic value of quality of life scores in terminal cancer patients. J Pain Symptom Manage 1996, 11: 32–341. 10.1016/0885-3924(95)00135-2PubMedCrossRef Tamburini M, Brunelli C, Rosso S, Ventafridda V: Prognostic value of quality of life scores in terminal cancer patients. J Pain Symptom Manage 1996, 11: 32–341. 10.1016/0885-3924(95)00135-2PubMedCrossRef

go back to reference Coates A, Porzsolt F, Osoba D: Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. Eur J Cancer 1997, 33: 1025–1030. 10.1016/S0959-8049(97)00049-XPubMedCrossRef Coates A, Porzsolt F, Osoba D: Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. Eur J Cancer 1997, 33: 1025–1030. 10.1016/S0959-8049(97)00049-XPubMedCrossRef

go back to reference Dancey J, Zee B, Osoba D, Whitehead M, Lu F, Kaizer L, Latreille J, Pater JL: Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy. The National Cancer Institute of Canada Clinical Trials Group. Qual Life Res 1997, 6: 151–158. 10.1023/A:1026442201191PubMedCrossRef Dancey J, Zee B, Osoba D, Whitehead M, Lu F, Kaizer L, Latreille J, Pater JL: Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy. The National Cancer Institute of Canada Clinical Trials Group. Qual Life Res 1997, 6: 151–158. 10.1023/A:1026442201191PubMedCrossRef

go back to reference Chang VT, Thaler HT, Polyak TA, Kornblith AB, Lepore JM, Portenoy RK: Quality of life and survival: the role of multidimensional symptom assessment. Cancer 1998, 83: 173–179. 10.1002/(SICI)1097-0142(19980701)83:1<173::AID-CNCR23>3.0.CO;2-TPubMedCrossRef Chang VT, Thaler HT, Polyak TA, Kornblith AB, Lepore JM, Portenoy RK: Quality of life and survival: the role of multidimensional symptom assessment. Cancer 1998, 83: 173–179. 10.1002/(SICI)1097-0142(19980701)83:1<173::AID-CNCR23>3.0.CO;2-TPubMedCrossRef

go back to reference Lam PT, Leung MW, Tse CY: Identifying prognostic factors for survival in advanced cancer patients: a prospective study. Hong Kong Med J 2007, 13: 453–459.PubMed Lam PT, Leung MW, Tse CY: Identifying prognostic factors for survival in advanced cancer patients: a prospective study. Hong Kong Med J 2007, 13: 453–459.PubMed

go back to reference Ganz PA, Lee JJ, Siau J: Quality of life assessment. An independent prognostic variable for survival in lung cancer. Cancer 1991, 67: 3131–3135. 10.1002/1097-0142(19910615)67:12<3131::AID-CNCR2820671232>3.0.CO;2-4PubMedCrossRef Ganz PA, Lee JJ, Siau J: Quality of life assessment. An independent prognostic variable for survival in lung cancer. Cancer 1991, 67: 3131–3135. 10.1002/1097-0142(19910615)67:12<3131::AID-CNCR2820671232>3.0.CO;2-4PubMedCrossRef

go back to reference Ruckdeschel JC, Piantadosi S: Quality of life in lung cancer surgical adjuvant trial. Chest 1994, 106: 324–328. 10.1378/chest.106.6.324SCrossRef Ruckdeschel JC, Piantadosi S: Quality of life in lung cancer surgical adjuvant trial. Chest 1994, 106: 324–328. 10.1378/chest.106.6.324SCrossRef

go back to reference Loprinzi CL, Laurie JA, Wieand HS, Krook JE, Novotny PJ, Kugler JW, Bartel J, Law M, Bateman M, Klatt NE, et al.: Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group. J Clin Oncol 1994, 12: 601–607.PubMed Loprinzi CL, Laurie JA, Wieand HS, Krook JE, Novotny PJ, Kugler JW, Bartel J, Law M, Bateman M, Klatt NE, et al.: Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group. J Clin Oncol 1994, 12: 601–607.PubMed

go back to reference Buccheri GF, Ferrigno D, Tamburini M, Brunelli C: The patient's perception of his own quality of life might have an adjunctive prognostic significance in lung cancer. Lung Cancer 1995, 12: 45–58. 10.1016/0169-5002(94)00392-ZPubMedCrossRef Buccheri GF, Ferrigno D, Tamburini M, Brunelli C: The patient's perception of his own quality of life might have an adjunctive prognostic significance in lung cancer. Lung Cancer 1995, 12: 45–58. 10.1016/0169-5002(94)00392-ZPubMedCrossRef

go back to reference Buccheri G: Depressive reactions to lung cancer are common and often followed by a poor outcome. Eur Respir J 1998, 11: 173–178. 10.1183/09031936.98.11010173PubMedCrossRef Buccheri G: Depressive reactions to lung cancer are common and often followed by a poor outcome. Eur Respir J 1998, 11: 173–178. 10.1183/09031936.98.11010173PubMedCrossRef

go back to reference Herndon JE, Fleishman S, Kornblith AB, Kosty M, Green MR, Holland J: Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma? Cancer 1999, 85: 333–340. 10.1002/(SICI)1097-0142(19990115)85:2<333::AID-CNCR10>3.0.CO;2-QPubMedCrossRef Herndon JE, Fleishman S, Kornblith AB, Kosty M, Green MR, Holland J: Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma? Cancer 1999, 85: 333–340. 10.1002/(SICI)1097-0142(19990115)85:2<333::AID-CNCR10>3.0.CO;2-QPubMedCrossRef

go back to reference Langendijk H, Aaronson NK, de Jong JM, ten Velde GP, Muller MJ, Wouters M: The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiother Oncol 2000, 55: 19–25. 10.1016/S0167-8140(00)00158-4PubMedCrossRef Langendijk H, Aaronson NK, de Jong JM, ten Velde GP, Muller MJ, Wouters M: The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiother Oncol 2000, 55: 19–25. 10.1016/S0167-8140(00)00158-4PubMedCrossRef

go back to reference Burrows CM, Mathews WC, Colt HG: Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease. Chest 2000, 117: 73–78. 10.1378/chest.117.1.73PubMedCrossRef Burrows CM, Mathews WC, Colt HG: Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease. Chest 2000, 117: 73–78. 10.1378/chest.117.1.73PubMedCrossRef

go back to reference Montazeri A, Milroy R, Hole D, McEwen J, Gillis CR: Quality of life in lung cancer patients: as an important prognostic factor. Lung Cancer 2001, 31: 233–240. 10.1016/S0169-5002(00)00179-3PubMedCrossRef Montazeri A, Milroy R, Hole D, McEwen J, Gillis CR: Quality of life in lung cancer patients: as an important prognostic factor. Lung Cancer 2001, 31: 233–240. 10.1016/S0169-5002(00)00179-3PubMedCrossRef

go back to reference Auchter RM, Scholtens D, Adak S, Wanger H, Cella DF, Mehta MP: Quality of life assessment in advanced non-small-cell lung cancer patients undergoing an accelerated radiotherapy regimen: report of ECOG study 4593. Int J Radiat Oncol Biol Phys 2001, 50: 1199–1206. 10.1016/S0360-3016(01)01604-2PubMedCrossRef Auchter RM, Scholtens D, Adak S, Wanger H, Cella DF, Mehta MP: Quality of life assessment in advanced non-small-cell lung cancer patients undergoing an accelerated radiotherapy regimen: report of ECOG study 4593. Int J Radiat Oncol Biol Phys 2001, 50: 1199–1206. 10.1016/S0360-3016(01)01604-2PubMedCrossRef

go back to reference Moinpour CM, Lyons B, Grevstad PK, Lovato LC, Growley J, Czaplicki K, Buckner ZM, Ganz PA, Kelly K, Gandara DR: Quality of life in advanced non-small-cell lung cancer: results of a Southwest Oncology Group randomized trial. Qual Life Res 2002, 11: 115–126. 10.1023/A:1015048908822PubMedCrossRef Moinpour CM, Lyons B, Grevstad PK, Lovato LC, Growley J, Czaplicki K, Buckner ZM, Ganz PA, Kelly K, Gandara DR: Quality of life in advanced non-small-cell lung cancer: results of a Southwest Oncology Group randomized trial. Qual Life Res 2002, 11: 115–126. 10.1023/A:1015048908822PubMedCrossRef

go back to reference Nakahara Y, Mochizuki Y, Miyamoto Y, Tanaka A, Kawamura T, Sasaki S, Nakahara Y, Katsura Y: Mental state as a possible independent prognostic variable for survival in patients with advanced lung carcinoma. Cancer 2002, 94: 3006–3015. 10.1002/cncr.10608PubMedCrossRef Nakahara Y, Mochizuki Y, Miyamoto Y, Tanaka A, Kawamura T, Sasaki S, Nakahara Y, Katsura Y: Mental state as a possible independent prognostic variable for survival in patients with advanced lung carcinoma. Cancer 2002, 94: 3006–3015. 10.1002/cncr.10608PubMedCrossRef

go back to reference Naughton MJ, Herndon JE, Shumaker SA, Miller AA, Kornblith AB, Chao D, Hollan J: The health - related quality of life and survival of small-cell lung cancer patients: Results of a companion study to CALGB 9033. Qual Life Res 2002, 11: 235–248. 10.1023/A:1015257121369PubMedCrossRef Naughton MJ, Herndon JE, Shumaker SA, Miller AA, Kornblith AB, Chao D, Hollan J: The health - related quality of life and survival of small-cell lung cancer patients: Results of a companion study to CALGB 9033. Qual Life Res 2002, 11: 235–248. 10.1023/A:1015257121369PubMedCrossRef

go back to reference Eton DT, Fairclough DJ, Cella D, Yount SE, Bonomi P, Johnson DH: Early change in patient-reported health during lung cancer chemotherapy predicts clinical outcomes beyond those predicted by baseline report: results from eastern cooperative oncology group study 5592. J Clin Oncol 2003, 21: 1536–1543. 10.1200/JCO.2003.07.128PubMedCrossRef Eton DT, Fairclough DJ, Cella D, Yount SE, Bonomi P, Johnson DH: Early change in patient-reported health during lung cancer chemotherapy predicts clinical outcomes beyond those predicted by baseline report: results from eastern cooperative oncology group study 5592. J Clin Oncol 2003, 21: 1536–1543. 10.1200/JCO.2003.07.128PubMedCrossRef

go back to reference Dharma-Wardene M, Au HJ, Hanson J, Dupere D, Hewitt J, Feeny D: Baseline FACT-G score is a predictor of survival for advanced lung cancer. Qual Life Res 2004, 13: 1209–1216. 10.1023/B:QURE.0000037481.36604.ebPubMedCrossRef Dharma-Wardene M, Au HJ, Hanson J, Dupere D, Hewitt J, Feeny D: Baseline FACT-G score is a predictor of survival for advanced lung cancer. Qual Life Res 2004, 13: 1209–1216. 10.1023/B:QURE.0000037481.36604.ebPubMedCrossRef

go back to reference Nowak AK, Stockler MR, Byrne MJ: Assessing quality of life during chemotherapy for pleural mesothelioma: feasibility, validity, and results of using the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire and Lung Cancer Module. J Clin Oncol 2004, 22: 3172–3180. 10.1200/JCO.2004.09.147PubMedCrossRef Nowak AK, Stockler MR, Byrne MJ: Assessing quality of life during chemotherapy for pleural mesothelioma: feasibility, validity, and results of using the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire and Lung Cancer Module. J Clin Oncol 2004, 22: 3172–3180. 10.1200/JCO.2004.09.147PubMedCrossRef

go back to reference Maione P, Perrone F, Gallo C, Manzione L, Piantedosi F, Barbera S, Cigolari S, Rosetti F, Piazza E, Robbiati SF, Bertetto O, Novello S, Migliorino MR, Favaretto A, Spatafora M, Ferraù F, Frontini L, Bearz A, Repetto L, Gridelli C, Barletta E, Barzelloni ML, Iaffaioli RV, De Maio E, Di Maio M, De Feo G, Sigoriello G, Chiodini P, Cioffi A, Guardasole V, Angelini V, Rossi A, Bilancia D, Germano D, Lamberti A, Pontillo V, Brancaccio L, Renda F, Romano F, Esani G, Gambaro A, Vinante O, Azzarello G, Clerici M, Bollina R, Belloni P, Sannicolò M, Ciuffreda L, Parello G, Cabiddu M, Sacco C, Sibau A, Porcile G, Castiglione F, Ostellino O, Monfardini S, Stefani M, Scagliotti G, Selvaggi G, De Marinis F, Martelli O, Gasparini G, Morabito A, Gattuso D, Colucci G, Galetta D, Giotta F, Gebbia V, Borsellino N, Testa A, Malaponte E, Capuano MA, Angiolillo M, Sollitto F, Tirelli U, Spazzapan S, Adamo V, Altavilla G, Scimone A, Hopps MR, Tartamella F, Ianniello GP, Tinessa V, Failla G, Bordonaro R, Gebbia N, Valerio MR, D'Aprile M, Veltri E, Tonato M, Darwish S, Romito S, Carrozza F, Barni S, Ardizzoia A, Corradini GM, Pavia G, Belli M, Colantuoni G, Galligioni E, Caffo O, Labianca R, Quadri A, Cortesi E, D'Auria G, Fava S, Calcagno A, Luporini G, Locatelli MC, Di Costanzo F, Gasperoni S, Isa L, Candido P, Gaion F, Palazzolo G, Nettis G, Annamaria A, Rinaldi M, Lopez M, Felletti R, Di Negro GB, Rossi N, Calandriello A, Maiorino L, Mattioli R, Celano A, Schiavon S, Illiano A, Raucci CA, Caruso M, Foa P, Tonini G, Curcio C, Cazzaniga M: Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study. J Clin Oncol 2005, 23: 6865–6872. 10.1200/JCO.2005.02.527PubMedCrossRef Maione P, Perrone F, Gallo C, Manzione L, Piantedosi F, Barbera S, Cigolari S, Rosetti F, Piazza E, Robbiati SF, Bertetto O, Novello S, Migliorino MR, Favaretto A, Spatafora M, Ferraù F, Frontini L, Bearz A, Repetto L, Gridelli C, Barletta E, Barzelloni ML, Iaffaioli RV, De Maio E, Di Maio M, De Feo G, Sigoriello G, Chiodini P, Cioffi A, Guardasole V, Angelini V, Rossi A, Bilancia D, Germano D, Lamberti A, Pontillo V, Brancaccio L, Renda F, Romano F, Esani G, Gambaro A, Vinante O, Azzarello G, Clerici M, Bollina R, Belloni P, Sannicolò M, Ciuffreda L, Parello G, Cabiddu M, Sacco C, Sibau A, Porcile G, Castiglione F, Ostellino O, Monfardini S, Stefani M, Scagliotti G, Selvaggi G, De Marinis F, Martelli O, Gasparini G, Morabito A, Gattuso D, Colucci G, Galetta D, Giotta F, Gebbia V, Borsellino N, Testa A, Malaponte E, Capuano MA, Angiolillo M, Sollitto F, Tirelli U, Spazzapan S, Adamo V, Altavilla G, Scimone A, Hopps MR, Tartamella F, Ianniello GP, Tinessa V, Failla G, Bordonaro R, Gebbia N, Valerio MR, D'Aprile M, Veltri E, Tonato M, Darwish S, Romito S, Carrozza F, Barni S, Ardizzoia A, Corradini GM, Pavia G, Belli M, Colantuoni G, Galligioni E, Caffo O, Labianca R, Quadri A, Cortesi E, D'Auria G, Fava S, Calcagno A, Luporini G, Locatelli MC, Di Costanzo F, Gasperoni S, Isa L, Candido P, Gaion F, Palazzolo G, Nettis G, Annamaria A, Rinaldi M, Lopez M, Felletti R, Di Negro GB, Rossi N, Calandriello A, Maiorino L, Mattioli R, Celano A, Schiavon S, Illiano A, Raucci CA, Caruso M, Foa P, Tonini G, Curcio C, Cazzaniga M: Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study. J Clin Oncol 2005, 23: 6865–6872. 10.1200/JCO.2005.02.527PubMedCrossRef

go back to reference Brown J, Thorpe H, Napp V, Fairlamb DJ, Gower NH, Milroy R, Parmar MK, Rudd RM, Spiro SG, Stephens RJ, Waller D, West P, Peake MD: Assessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancer. J Clin Oncol 2005, 23: 7417–727. 10.1200/JCO.2005.09.158PubMedCrossRef Brown J, Thorpe H, Napp V, Fairlamb DJ, Gower NH, Milroy R, Parmar MK, Rudd RM, Spiro SG, Stephens RJ, Waller D, West P, Peake MD: Assessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancer. J Clin Oncol 2005, 23: 7417–727. 10.1200/JCO.2005.09.158PubMedCrossRef

go back to reference Martins SJ, Ho N, Cavamura SO, Harada CM, Yamamoto CA, Takagaki TY: Lung cancer symptoms and pulse oximetry in the prognostic assessment of patients with lung cancer. BMC Cancer 2005, 5: 72. 10.1186/1471-2407-5-72PubMedPubMedCentralCrossRef Martins SJ, Ho N, Cavamura SO, Harada CM, Yamamoto CA, Takagaki TY: Lung cancer symptoms and pulse oximetry in the prognostic assessment of patients with lung cancer. BMC Cancer 2005, 5: 72. 10.1186/1471-2407-5-72PubMedPubMedCentralCrossRef

go back to reference Efficace F, Bottomley A, Smit EF, Lianes P, Legrand C, Debruyne C, Schramel F, Smit HJ, Gaafar R, Biesma B, Manegold C, Coens C, Giaccone G, Van Meerbeeck J, the EORTC Lung Cancer Group and Quality of Life Unit: Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975. Ann Oncol 2006, 17: 1698–1704. 10.1093/annonc/mdl183PubMedCrossRef Efficace F, Bottomley A, Smit EF, Lianes P, Legrand C, Debruyne C, Schramel F, Smit HJ, Gaafar R, Biesma B, Manegold C, Coens C, Giaccone G, Van Meerbeeck J, the EORTC Lung Cancer Group and Quality of Life Unit: Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975. Ann Oncol 2006, 17: 1698–1704. 10.1093/annonc/mdl183PubMedCrossRef

go back to reference Sundstrøm S, Bremnes RM, Brunsvig P, Aasebø U, Kaasa S, Norwegian Lung Cancer Study Group: Palliative thoracic radiotherapy in locally advanced non-small cell lung cancer: can quality-of-life assessments help in selection of patients for short- or long-course radiotherapy? J Thorac Oncol 2006, 1: 816–824. 10.1097/01243894-200610000-00010PubMedCrossRef Sundstrøm S, Bremnes RM, Brunsvig P, Aasebø U, Kaasa S, Norwegian Lung Cancer Study Group: Palliative thoracic radiotherapy in locally advanced non-small cell lung cancer: can quality-of-life assessments help in selection of patients for short- or long-course radiotherapy? J Thorac Oncol 2006, 1: 816–824. 10.1097/01243894-200610000-00010PubMedCrossRef

go back to reference Bottomley A, Coens C, Efficace F, Gaafar R, Manegold C, Burgers S, Vincent M, Legrand C, van Meerbeeck JP, EORTC-NCIC: Symptoms and patient-reported well-being: do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTC-NCIC 08983: randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma. J Clin Oncol 2007, 25: 5770–5776. 10.1200/JCO.2007.12.5294PubMedCrossRef Bottomley A, Coens C, Efficace F, Gaafar R, Manegold C, Burgers S, Vincent M, Legrand C, van Meerbeeck JP, EORTC-NCIC: Symptoms and patient-reported well-being: do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTC-NCIC 08983: randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma. J Clin Oncol 2007, 25: 5770–5776. 10.1200/JCO.2007.12.5294PubMedCrossRef

go back to reference Fielding R, Wong WS: Quality of life as a predictor of cancer survival among Chinese liver and lung cancer patients. Eur J Cancer 2007, 43: 1723–1730. 10.1016/j.ejca.2007.05.002PubMedCrossRef Fielding R, Wong WS: Quality of life as a predictor of cancer survival among Chinese liver and lung cancer patients. Eur J Cancer 2007, 43: 1723–1730. 10.1016/j.ejca.2007.05.002PubMedCrossRef

go back to reference Jacot W, Colinet B, Bertrand D, Lacombe S, Bozonnat MC, Daurès JP, Pujol JL, OncoLR health network: Quality of life and comorbidity score as prognostic determinants in non-small-cell lung cancer patients. Ann Oncol 2008, 19: 1458–1464. 10.1093/annonc/mdn064PubMedCrossRef Jacot W, Colinet B, Bertrand D, Lacombe S, Bozonnat MC, Daurès JP, Pujol JL, OncoLR health network: Quality of life and comorbidity score as prognostic determinants in non-small-cell lung cancer patients. Ann Oncol 2008, 19: 1458–1464. 10.1093/annonc/mdn064PubMedCrossRef

go back to reference Coates A, Gebski V, Signorini D, Murray P, McNeil D, Byne M, Forbes JF: Prognostic value of quality of life scores during chemotherapy for advanced breast cancer. J Clin Oncol 1992, 10: 1833–1838.PubMed Coates A, Gebski V, Signorini D, Murray P, McNeil D, Byne M, Forbes JF: Prognostic value of quality of life scores during chemotherapy for advanced breast cancer. J Clin Oncol 1992, 10: 1833–1838.PubMed

go back to reference Fraser SC, Ramirez AJ, Ebbes SR, Fallowfield LJ, Dobbs HJ, Richards MA, Bates T, Baum M: A daily diary for quality of life measurement in advanced breast cancer trials. Br J Cancer 1993, 67: 341–346.PubMedPubMedCentralCrossRef Fraser SC, Ramirez AJ, Ebbes SR, Fallowfield LJ, Dobbs HJ, Richards MA, Bates T, Baum M: A daily diary for quality of life measurement in advanced breast cancer trials. Br J Cancer 1993, 67: 341–346.PubMedPubMedCentralCrossRef

go back to reference Seidman AD, Portenoy R, Yao TJ, Lepore J, Mont EK, Kortmansky J, Onetto N, Ren L, Grechko J, Beltangady M, et al.: Quality of life in phase II trials-A study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel, plus granulocyte colony stimulating factor. J Natl Cancer Inst 1995, 187: 1316–1322. 10.1093/jnci/87.17.1316CrossRef Seidman AD, Portenoy R, Yao TJ, Lepore J, Mont EK, Kortmansky J, Onetto N, Ren L, Grechko J, Beltangady M, et al.: Quality of life in phase II trials-A study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel, plus granulocyte colony stimulating factor. J Natl Cancer Inst 1995, 187: 1316–1322. 10.1093/jnci/87.17.1316CrossRef

go back to reference Tross S, Herndon J, Korzun A, Kornblith AB, Cella DF, Herndon JF, Raich P, Johnson A, Kiang DT, Perloff M, Norton L, Wood W, Holland JC, From the Cancer and Leukemia Group B: Psychosocial symptoms and disease-free and overall survival in women with stage II breast cancer. J Natl Cancer Inst 1996, 88: 661–667. 10.1093/jnci/88.10.661PubMedCrossRef Tross S, Herndon J, Korzun A, Kornblith AB, Cella DF, Herndon JF, Raich P, Johnson A, Kiang DT, Perloff M, Norton L, Wood W, Holland JC, From the Cancer and Leukemia Group B: Psychosocial symptoms and disease-free and overall survival in women with stage II breast cancer. J Natl Cancer Inst 1996, 88: 661–667. 10.1093/jnci/88.10.661PubMedCrossRef

go back to reference Watson M, Haviland JS, Greer S, Davidson J, Bliss JM: Influence of psychological response on survival in breast cancer: a population-based cohort study. Lancet 1999, 16: 1331–1336. 10.1016/S0140-6736(98)11392-2CrossRef Watson M, Haviland JS, Greer S, Davidson J, Bliss JM: Influence of psychological response on survival in breast cancer: a population-based cohort study. Lancet 1999, 16: 1331–1336. 10.1016/S0140-6736(98)11392-2CrossRef

go back to reference Coates AS, Hurny C, Peterson HF, Bernhard J, Castinglione-Gertsch M, Gelberg D, Goldhirsch A: Quality of life scores predict outcome in metastatic but not early breast cancer. J Clin Oncol 2000, 18: 3768–3774.PubMed Coates AS, Hurny C, Peterson HF, Bernhard J, Castinglione-Gertsch M, Gelberg D, Goldhirsch A: Quality of life scores predict outcome in metastatic but not early breast cancer. J Clin Oncol 2000, 18: 3768–3774.PubMed

go back to reference Kramer JA, Curran D, Piccart M, de Haes JC, Bruning PF, Klijn JG, van Hoorebeeck I, Paridaens R: Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in firs-line chemotherapy in advanced breast cancer. Eur J Cancer 2000, 36: 1498–1506. 10.1016/S0959-8049(00)00144-1PubMedCrossRef Kramer JA, Curran D, Piccart M, de Haes JC, Bruning PF, Klijn JG, van Hoorebeeck I, Paridaens R: Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in firs-line chemotherapy in advanced breast cancer. Eur J Cancer 2000, 36: 1498–1506. 10.1016/S0959-8049(00)00144-1PubMedCrossRef

go back to reference Shimozuma K, Sonoo H, Ichihara K, Tanaka K: The prognostic value of quality of life scores: preliminary results of an analysis of patients with breast cancer. Surg Today 2000, 30: 255–261. 10.1007/s005950050055PubMedCrossRef Shimozuma K, Sonoo H, Ichihara K, Tanaka K: The prognostic value of quality of life scores: preliminary results of an analysis of patients with breast cancer. Surg Today 2000, 30: 255–261. 10.1007/s005950050055PubMedCrossRef

go back to reference Butow PN, Coates AS, Dunn SM: Psychosocial predictors of survival: metastatic breast cancer. Ann Oncol 2000, 11: 469–474. 10.1023/A:1008396330433PubMedCrossRef Butow PN, Coates AS, Dunn SM: Psychosocial predictors of survival: metastatic breast cancer. Ann Oncol 2000, 11: 469–474. 10.1023/A:1008396330433PubMedCrossRef

go back to reference Luoma ML, Hakamies-Blomqvist L, Sjostrom J, Pluzanska A, Ottoson S, Mouridsen H, Bengtsson NO, Bergh J, Malmstrom P, Valvere V, Tennvall L, Blomqvist C: Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer. Eur J Cancer 2003, 39: 1370–1376. 10.1016/S0959-8049(02)00775-XPubMedCrossRef Luoma ML, Hakamies-Blomqvist L, Sjostrom J, Pluzanska A, Ottoson S, Mouridsen H, Bengtsson NO, Bergh J, Malmstrom P, Valvere V, Tennvall L, Blomqvist C: Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer. Eur J Cancer 2003, 39: 1370–1376. 10.1016/S0959-8049(02)00775-XPubMedCrossRef

go back to reference Winer EP, Berry DA, Woolf S, Duggan D, Kornblith A, Harris LN, Michaelson RA, Kirshner JA, Fleming GF, Perry MC, Graham ML, Sharp SA, Keresztes R, Henderson IC, Hudis C, Muss H, Norton L: Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342. J Clin Oncol 2004, 22: 2061–2068. 10.1200/JCO.2004.08.048PubMedCrossRef Winer EP, Berry DA, Woolf S, Duggan D, Kornblith A, Harris LN, Michaelson RA, Kirshner JA, Fleming GF, Perry MC, Graham ML, Sharp SA, Keresztes R, Henderson IC, Hudis C, Muss H, Norton L: Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342. J Clin Oncol 2004, 22: 2061–2068. 10.1200/JCO.2004.08.048PubMedCrossRef

go back to reference Efficace F, Therasse P, Piccart MJ, Coens C, van Steen K, Welnicka-Jaskiewicz M, Cufer T, Dyczka J, Lichinitser M, Shepherd L, de Haes H, Sprangers MA, Bottomley A: Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population: an international multicenter study. J Clin Oncol 2004, 22: 3381–3388. 10.1200/JCO.2004.02.060PubMedCrossRef Efficace F, Therasse P, Piccart MJ, Coens C, van Steen K, Welnicka-Jaskiewicz M, Cufer T, Dyczka J, Lichinitser M, Shepherd L, de Haes H, Sprangers MA, Bottomley A: Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population: an international multicenter study. J Clin Oncol 2004, 22: 3381–3388. 10.1200/JCO.2004.02.060PubMedCrossRef

go back to reference Efficace F, Biganzoli L, Piccart M, Coens C, van Steen K, Cufer T, Coleman RE, Calvert HA, Gamucci T, Twelves C, Fargeot P, Bottomley A: Baseline health-related quality of life data as prognostic factors in a phase III multicenter study of women with metastatic breast cancer. Eur J Cancer 2004, 40: 1021–1030. 10.1016/j.ejca.2004.01.014PubMedCrossRef Efficace F, Biganzoli L, Piccart M, Coens C, van Steen K, Cufer T, Coleman RE, Calvert HA, Gamucci T, Twelves C, Fargeot P, Bottomley A: Baseline health-related quality of life data as prognostic factors in a phase III multicenter study of women with metastatic breast cancer. Eur J Cancer 2004, 40: 1021–1030. 10.1016/j.ejca.2004.01.014PubMedCrossRef

go back to reference Goodwin PJ, Ennis M, Bordeleau LJ, Pritchard KT, Trudeau Me, Koo J, Hood N: Health-related quality of life and psychosocial status in breast cancer prognosis: analysis of multiple variables. J Clin Oncol 2004, 22: 4184–4192. 10.1200/JCO.2004.12.091PubMedCrossRef Goodwin PJ, Ennis M, Bordeleau LJ, Pritchard KT, Trudeau Me, Koo J, Hood N: Health-related quality of life and psychosocial status in breast cancer prognosis: analysis of multiple variables. J Clin Oncol 2004, 22: 4184–4192. 10.1200/JCO.2004.12.091PubMedCrossRef

go back to reference Watson M, Homewood J, Haviland J, Bliss J: Influence of psychosocial response on breast cancer survival: 10-year follow-up of a population-based cohort. European Journal of Cancer 2005, 41: 1710–1714. 10.1016/j.ejca.2005.01.012PubMedCrossRef Watson M, Homewood J, Haviland J, Bliss J: Influence of psychosocial response on breast cancer survival: 10-year follow-up of a population-based cohort. European Journal of Cancer 2005, 41: 1710–1714. 10.1016/j.ejca.2005.01.012PubMedCrossRef

go back to reference Lehto US, Ojanen M, Dyba T, Aromaa A, Kellokumpu Lehtinen P: Baseline psychosocial predictors of survival in localized breast cancer. Br J Cancer 2006, 94: 1245–1252. 10.1038/sj.bjc.6603091PubMedPubMedCentralCrossRef Lehto US, Ojanen M, Dyba T, Aromaa A, Kellokumpu Lehtinen P: Baseline psychosocial predictors of survival in localized breast cancer. Br J Cancer 2006, 94: 1245–1252. 10.1038/sj.bjc.6603091PubMedPubMedCentralCrossRef

go back to reference Gupta D, Granick J, Grutsch JF, Lis CG: The prognostic association of health-related quality of life scores with survival in breast cancer. Support Care Cancer 2007, 15: 387–393. 10.1007/s00520-006-0165-zPubMedCrossRef Gupta D, Granick J, Grutsch JF, Lis CG: The prognostic association of health-related quality of life scores with survival in breast cancer. Support Care Cancer 2007, 15: 387–393. 10.1007/s00520-006-0165-zPubMedCrossRef

go back to reference Groenvold M, Petersen MA, Idler E, Bjorner JB, Fayers PM, Mouridsen HT: Psychosocial distress and fatigue predicted recurrence and survival in primary breast cancer patients. Br J Cancer 2007, 105: 209–219. Groenvold M, Petersen MA, Idler E, Bjorner JB, Fayers PM, Mouridsen HT: Psychosocial distress and fatigue predicted recurrence and survival in primary breast cancer patients. Br J Cancer 2007, 105: 209–219.

go back to reference Blazeby JM, Brookes ST, Alderson D: Prognostic value of quality of life scores in patients with oesophageal cancer. Br J Surg 2000, 87: 362–373. 10.1046/j.1365-2168.2000.01383-8.xCrossRef Blazeby JM, Brookes ST, Alderson D: Prognostic value of quality of life scores in patients with oesophageal cancer. Br J Surg 2000, 87: 362–373. 10.1046/j.1365-2168.2000.01383-8.xCrossRef

go back to reference Blazeby JM, Brookes ST, Alderson D: The prpognostic value of quality of life scores during treatment for oesophageal cancer. Gut 2001, 49: 227–230. 10.1136/gut.49.2.227PubMedPubMedCentralCrossRef Blazeby JM, Brookes ST, Alderson D: The prpognostic value of quality of life scores during treatment for oesophageal cancer. Gut 2001, 49: 227–230. 10.1136/gut.49.2.227PubMedPubMedCentralCrossRef

go back to reference Fang FM, Tsai WL, Chiu HC, Kuo WR, Hsiung CY: Quality of life as a survival predictor for esophageal squamous cell carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys 2004, 58: 1394–1404. 10.1016/j.ijrobp.2003.09.100PubMedCrossRef Fang FM, Tsai WL, Chiu HC, Kuo WR, Hsiung CY: Quality of life as a survival predictor for esophageal squamous cell carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys 2004, 58: 1394–1404. 10.1016/j.ijrobp.2003.09.100PubMedCrossRef

go back to reference Chau I, Norman AR, Cunningham D, Waters JS, Oates J: Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer: pooled analysis from three multicenter, randomized, controlled trials using individual patient data. J Clin Oncol 2004, 22: 2395–2403. 10.1200/JCO.2004.08.154PubMedCrossRef Chau I, Norman AR, Cunningham D, Waters JS, Oates J: Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer: pooled analysis from three multicenter, randomized, controlled trials using individual patient data. J Clin Oncol 2004, 22: 2395–2403. 10.1200/JCO.2004.08.154PubMedCrossRef

go back to reference Park SH, Cho MS, Kim YS, Hong J, Nam E, Park J, Cho EK, Shin DB, Lee JH, Lee WK: Self-reported health-related quality of life predicts survival for patients with advanced gastric cancer treated with first-line chemotherapy. Qual Life Res 2008, 17: 207–214. 10.1007/s11136-008-9307-8PubMedCrossRef Park SH, Cho MS, Kim YS, Hong J, Nam E, Park J, Cho EK, Shin DB, Lee JH, Lee WK: Self-reported health-related quality of life predicts survival for patients with advanced gastric cancer treated with first-line chemotherapy. Qual Life Res 2008, 17: 207–214. 10.1007/s11136-008-9307-8PubMedCrossRef

go back to reference Bergquist H, Johnsson A, Hammerlid E, Wenger U, Lundell L, Ruth M: Factors predicting survival in patients with advanced oesophageal cancer: a prospective multicentre evaluation. Aliment Pharmacol Ther 2008, 27: 385–395. 10.1111/j.1365-2036.2007.03589.xPubMedCrossRef Bergquist H, Johnsson A, Hammerlid E, Wenger U, Lundell L, Ruth M: Factors predicting survival in patients with advanced oesophageal cancer: a prospective multicentre evaluation. Aliment Pharmacol Ther 2008, 27: 385–395. 10.1111/j.1365-2036.2007.03589.xPubMedCrossRef

go back to reference McKernan M, Mcmillan Dc, Anderson JR, Angerson WJ, Stuart RC: The relationship between quality of life (EORT QLQ-C30) and survival in patients with gastro-oesophageal cancer. Br J Cancer 2008, 98: 888–893. 10.1038/sj.bjc.6604248PubMedPubMedCentralCrossRef McKernan M, Mcmillan Dc, Anderson JR, Angerson WJ, Stuart RC: The relationship between quality of life (EORT QLQ-C30) and survival in patients with gastro-oesophageal cancer. Br J Cancer 2008, 98: 888–893. 10.1038/sj.bjc.6604248PubMedPubMedCentralCrossRef

go back to reference Healy LA, Ryan AM, Moore J, Rowley S, Ravi N, Byrne PJ, Reynolds JV: Health-related quality of life assessment at presentation may predict complications and early relapse in patients with localized cancer of the esophagus. Dis Esophagus 2008, 21: 522–528. 10.1111/j.1442-2050.2008.00814.xPubMedCrossRef Healy LA, Ryan AM, Moore J, Rowley S, Ravi N, Byrne PJ, Reynolds JV: Health-related quality of life assessment at presentation may predict complications and early relapse in patients with localized cancer of the esophagus. Dis Esophagus 2008, 21: 522–528. 10.1111/j.1442-2050.2008.00814.xPubMedCrossRef

go back to reference Earlam S, Glover C, Fordy C, Burke D, Allen-Mersh TG: Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases. J Clin Oncol 1996, 14: 171–175.PubMed Earlam S, Glover C, Fordy C, Burke D, Allen-Mersh TG: Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases. J Clin Oncol 1996, 14: 171–175.PubMed

go back to reference Maisey NR, Norman A, Watson M, Allen MJ, Hill ME, Cunningham D: Baseline quality of life predicts survival in patients with advanced colorectal cancer. Eur J Cancer 2002, 38: 1351–1357. 10.1016/S0959-8049(02)00098-9PubMedCrossRef Maisey NR, Norman A, Watson M, Allen MJ, Hill ME, Cunningham D: Baseline quality of life predicts survival in patients with advanced colorectal cancer. Eur J Cancer 2002, 38: 1351–1357. 10.1016/S0959-8049(02)00098-9PubMedCrossRef

go back to reference Lis CG, Gupta D, Granick J, Grutsch JF: Can patient satisfaction with quality of life predict survival in advanced colorectal cancer? Support Care Cancer 2006, 14: 1104–1110. 10.1007/s00520-006-0100-3PubMedCrossRef Lis CG, Gupta D, Granick J, Grutsch JF: Can patient satisfaction with quality of life predict survival in advanced colorectal cancer? Support Care Cancer 2006, 14: 1104–1110. 10.1007/s00520-006-0100-3PubMedCrossRef

go back to reference Efficace F, Bottomley A, Coens C, Van Steen K, Conroy T, Schöffski P, Schmoll H, Van Cutsem E, Köhne CH: Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer? Eur J Cancer 2006, 42: 42–49. 10.1016/j.ejca.2005.07.025PubMedCrossRef Efficace F, Bottomley A, Coens C, Van Steen K, Conroy T, Schöffski P, Schmoll H, Van Cutsem E, Köhne CH: Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer? Eur J Cancer 2006, 42: 42–49. 10.1016/j.ejca.2005.07.025PubMedCrossRef

go back to reference Efficace F, Innominato PF, Bjarnason G, Coens C, Humblet Y, Tumolo S, Genet D, Tampellini M, Bottomley A, Garufi C, Focan C, Giacchetti S, Lévi F, Chronotherapy Group of the European Organisation for Research and Treatment of Cancer: Validation of patient's self-reported social functioning as an independent prognostic factor for survival in metastatic colorectal cancer patients: results of an international study by the Chronotherapy Group of the European Organization for Research and Treatment of Cancer. J Clin Oncol 2008, 26: 2020–2026. 10.1200/JCO.2007.12.3117PubMedCrossRef Efficace F, Innominato PF, Bjarnason G, Coens C, Humblet Y, Tumolo S, Genet D, Tampellini M, Bottomley A, Garufi C, Focan C, Giacchetti S, Lévi F, Chronotherapy Group of the European Organisation for Research and Treatment of Cancer: Validation of patient's self-reported social functioning as an independent prognostic factor for survival in metastatic colorectal cancer patients: results of an international study by the Chronotherapy Group of the European Organization for Research and Treatment of Cancer. J Clin Oncol 2008, 26: 2020–2026. 10.1200/JCO.2007.12.3117PubMedCrossRef

go back to reference De Boer MF, Borne B, Pruyn JF, Ryckman RM, Volovics L, Knegt PP, Meeuwis CA, Mesters I, Verwoerd CD: Psychosocial and physical correlates of survival and recurrence in patients with head and neck carcinoma: results of a 6-year longitudinal study. Cancer 1998, 83: 2567–2579. 10.1002/(SICI)1097-0142(19981215)83:12<2567::AID-CNCR24>3.0.CO;2-XPubMedCrossRef De Boer MF, Borne B, Pruyn JF, Ryckman RM, Volovics L, Knegt PP, Meeuwis CA, Mesters I, Verwoerd CD: Psychosocial and physical correlates of survival and recurrence in patients with head and neck carcinoma: results of a 6-year longitudinal study. Cancer 1998, 83: 2567–2579. 10.1002/(SICI)1097-0142(19981215)83:12<2567::AID-CNCR24>3.0.CO;2-XPubMedCrossRef

go back to reference de Graeff A, de Leeuw JR, Row WJ, Hordijk GJ, Blijham GH, Winnubst JA: Sociodemographic factors and quality of life as prognostic indicators in head and neck cancer. Eur J Cancer 2001, 37: 332–339. 10.1016/S0959-8049(00)00385-3PubMedCrossRef de Graeff A, de Leeuw JR, Row WJ, Hordijk GJ, Blijham GH, Winnubst JA: Sociodemographic factors and quality of life as prognostic indicators in head and neck cancer. Eur J Cancer 2001, 37: 332–339. 10.1016/S0959-8049(00)00385-3PubMedCrossRef

go back to reference Fang FM, Liu YT, Tang Y, Wang CJ, Ko SF: Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy. Cancer 2004, 100: 425–432. 10.1002/cncr.20010PubMedCrossRef Fang FM, Liu YT, Tang Y, Wang CJ, Ko SF: Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy. Cancer 2004, 100: 425–432. 10.1002/cncr.20010PubMedCrossRef

go back to reference Mehanna HM, Morton RP: Does quality of life predict long-term survival in head and neck cancer patients. Arch Otolaryngol Head Neck Surg 2006, 132: 27–31. 10.1001/archotol.132.1.27PubMedCrossRef Mehanna HM, Morton RP: Does quality of life predict long-term survival in head and neck cancer patients. Arch Otolaryngol Head Neck Surg 2006, 132: 27–31. 10.1001/archotol.132.1.27PubMedCrossRef

go back to reference Nordgren M, Jannert M, Boysen M, et al.: Health-related quality of life in patients with pharyngeal carcinoma: a five year follow-up. Head Neck 2006, 28: 339–349. 10.1002/hed.20334PubMedCrossRef Nordgren M, Jannert M, Boysen M, et al.: Health-related quality of life in patients with pharyngeal carcinoma: a five year follow-up. Head Neck 2006, 28: 339–349. 10.1002/hed.20334PubMedCrossRef

go back to reference Coyne JC, Pajak TF, Harris J, Konski A, Movsas B, Ang K, Watkins Bruner D, Radiation Therapy Oncology Group: Emotional well-being does not predict survival in head and neck cancer patients: a Radiation Therapy Oncology Group study. Cancer 2007, 110: 2568–2575. 10.1002/cncr.23080PubMedCrossRef Coyne JC, Pajak TF, Harris J, Konski A, Movsas B, Ang K, Watkins Bruner D, Radiation Therapy Oncology Group: Emotional well-being does not predict survival in head and neck cancer patients: a Radiation Therapy Oncology Group study. Cancer 2007, 110: 2568–2575. 10.1002/cncr.23080PubMedCrossRef

go back to reference Siddiqui F, Pajak TF, Watkins-Bruner D, Konski AA, Coyne JC, Gwede CK, Garden AS, Spencer SA, Jones C, Movsas B: Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: a radiation therapy oncology group analysis. Int J Radiat Oncol Biol Phys 2008, 70: 353–360. 10.1016/j.ijrobp.2007.06.024PubMedCrossRef Siddiqui F, Pajak TF, Watkins-Bruner D, Konski AA, Coyne JC, Gwede CK, Garden AS, Spencer SA, Jones C, Movsas B: Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: a radiation therapy oncology group analysis. Int J Radiat Oncol Biol Phys 2008, 70: 353–360. 10.1016/j.ijrobp.2007.06.024PubMedCrossRef

go back to reference Karvonen-Gutierrez CA, Ronis DI, Fowler KE, Terrell JE, gruber SB, Duffy SA: Quality of life scores predict survival among patients with head and neck cancer. J Clin Oncol 2008, 26: 2754–2760. 10.1200/JCO.2007.12.9510PubMedCrossRef Karvonen-Gutierrez CA, Ronis DI, Fowler KE, Terrell JE, gruber SB, Duffy SA: Quality of life scores predict survival among patients with head and neck cancer. J Clin Oncol 2008, 26: 2754–2760. 10.1200/JCO.2007.12.9510PubMedCrossRef

go back to reference Mehanna HM, De Boer MF, Morton RP: The association of psycho-social and survival in head and neck cancer. Clin Otolaryngol 2008, 33: 83–89. 10.1111/j.1749-4486.2008.01666.xPubMedCrossRef Mehanna HM, De Boer MF, Morton RP: The association of psycho-social and survival in head and neck cancer. Clin Otolaryngol 2008, 33: 83–89. 10.1111/j.1749-4486.2008.01666.xPubMedCrossRef

go back to reference Cassileth BR, Walsh WP, Lusk EJ: Psychosocial correlates of cancer survival: a subsequent report 3 to 8 years after cancer diagnosis. J Clin Oncol 1988, 6: 1753–1759.PubMed Cassileth BR, Walsh WP, Lusk EJ: Psychosocial correlates of cancer survival: a subsequent report 3 to 8 years after cancer diagnosis. J Clin Oncol 1988, 6: 1753–1759.PubMed

go back to reference Coates A, Thomson D, McLeod GR, Hersey P, Gill PG, Olver IN, Kefford R, Lowenthal RM, Beadle G, Walpole E: Prognostic value of quality of life scores in a trial of Chemotherapy with or without interferon in patients with metastatic malignant melanoma. Eur J Cancer 1993, 29: 1731–1734. 10.1016/0959-8049(93)90115-VCrossRef Coates A, Thomson D, McLeod GR, Hersey P, Gill PG, Olver IN, Kefford R, Lowenthal RM, Beadle G, Walpole E: Prognostic value of quality of life scores in a trial of Chemotherapy with or without interferon in patients with metastatic malignant melanoma. Eur J Cancer 1993, 29: 1731–1734. 10.1016/0959-8049(93)90115-VCrossRef

go back to reference Butow PN, Coates AS, Dunn SM: Psychosocial predictors of survival in metastatic melanoma. J Clin Oncol 1999, 17: 2256.PubMed Butow PN, Coates AS, Dunn SM: Psychosocial predictors of survival in metastatic melanoma. J Clin Oncol 1999, 17: 2256.PubMed

go back to reference Brown JE, Butow PN, Culjak G, Coates AS, Dunn SM: Psychosocial predictors of outcome: time to relapse and survival in patients with early stage melanoma. Br J Cancer 2000, 83: 1448–1453. 10.1054/bjoc.2000.1471PubMedPubMedCentralCrossRef Brown JE, Butow PN, Culjak G, Coates AS, Dunn SM: Psychosocial predictors of outcome: time to relapse and survival in patients with early stage melanoma. Br J Cancer 2000, 83: 1448–1453. 10.1054/bjoc.2000.1471PubMedPubMedCentralCrossRef

go back to reference Chiarion-Sileni V, Del Bianco P, De Salvo GL, Lo Re G, Romanini A, Labianca R, Nortilli R, Corgna E, Dalla Palma M, Lo Presti G, Ridolfi R, Italian Melanoma Intergroup (IMI): Quality of life evaluation in a randomized trial of chemotherapy versus bio-chemotherapy in advanced melanoma patients. Eur J Cancer 2003, 39: 1577–1585. 10.1016/S0959-8049(03)00372-1PubMedCrossRef Chiarion-Sileni V, Del Bianco P, De Salvo GL, Lo Re G, Romanini A, Labianca R, Nortilli R, Corgna E, Dalla Palma M, Lo Presti G, Ridolfi R, Italian Melanoma Intergroup (IMI): Quality of life evaluation in a randomized trial of chemotherapy versus bio-chemotherapy in advanced melanoma patients. Eur J Cancer 2003, 39: 1577–1585. 10.1016/S0959-8049(03)00372-1PubMedCrossRef

go back to reference Lehto US, Ojanen M, Dyba T, Aromaa A, Kellokumpu Lehtinen P: Baseline psychosocial predictors of survival in localized melanoma. J Psychosom Res 2007, 63: 9–15. 10.1016/j.jpsychores.2007.01.001PubMedCrossRef Lehto US, Ojanen M, Dyba T, Aromaa A, Kellokumpu Lehtinen P: Baseline psychosocial predictors of survival in localized melanoma. J Psychosom Res 2007, 63: 9–15. 10.1016/j.jpsychores.2007.01.001PubMedCrossRef

go back to reference Andrykowski MA, brady MJ, Henslee-Downey PJ: Psychosocial factors predictive of survival after allogeneic bone marrow transplantation for leukemia. Psychosom Med 1994, 56: 432–439.PubMedCrossRef Andrykowski MA, brady MJ, Henslee-Downey PJ: Psychosocial factors predictive of survival after allogeneic bone marrow transplantation for leukemia. Psychosom Med 1994, 56: 432–439.PubMedCrossRef

go back to reference Tannock IF, Osoba D, Stockler MR, Ernst DS, Neville AJ, Moore MJ, Armitage GR, Wilson JJ, Venner PM, Coppin CM, Murphy KC: Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points. J Clin Oncol 1996, 14: 1753–1755. Tannock IF, Osoba D, Stockler MR, Ernst DS, Neville AJ, Moore MJ, Armitage GR, Wilson JJ, Venner PM, Coppin CM, Murphy KC: Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points. J Clin Oncol 1996, 14: 1753–1755.

go back to reference Wisløff F, Hjorth M: Health-related quality of life assessed before and during chemotherapy predicts for survival in multiple myeloma. Nordic Myeloma Study Group. Br J Haematol 1997, 97: 29–37. 10.1046/j.1365-2141.1997.222667.xPubMedCrossRef Wisløff F, Hjorth M: Health-related quality of life assessed before and during chemotherapy predicts for survival in multiple myeloma. Nordic Myeloma Study Group. Br J Haematol 1997, 97: 29–37. 10.1046/j.1365-2141.1997.222667.xPubMedCrossRef

go back to reference Meyers CA, Hess KR, Yung WK, Levin VA: Cognitive function as predictor of survival in patients with recurrent malignant glioma. J Clin Oncol 2000, 18: 646–650.PubMed Meyers CA, Hess KR, Yung WK, Levin VA: Cognitive function as predictor of survival in patients with recurrent malignant glioma. J Clin Oncol 2000, 18: 646–650.PubMed

go back to reference Jerkeman M, Kaasa S, Hjermstad M, Kvaløy S, Cavallin-Stahl E: Health-related quality of life and its potential prognostic implications in patients with aggressive lymphoma: a Nordic Lymphoma Group Trial. Med Oncol 2001, 18: 85–94. 10.1385/MO:18:1:85PubMedCrossRef Jerkeman M, Kaasa S, Hjermstad M, Kvaløy S, Cavallin-Stahl E: Health-related quality of life and its potential prognostic implications in patients with aggressive lymphoma: a Nordic Lymphoma Group Trial. Med Oncol 2001, 18: 85–94. 10.1385/MO:18:1:85PubMedCrossRef

go back to reference Roychowdhury DF, Hayden A, Liepa AM: Health-related quality-of-life parameters as independent prognostic factors in advanced or metastatic bladder cancer. J Clin Oncol 2003, 21: 673–678. 10.1200/JCO.2003.04.166PubMedCrossRef Roychowdhury DF, Hayden A, Liepa AM: Health-related quality-of-life parameters as independent prognostic factors in advanced or metastatic bladder cancer. J Clin Oncol 2003, 21: 673–678. 10.1200/JCO.2003.04.166PubMedCrossRef

go back to reference Sehlen S, Lenk M, Hollenhorst H, Schymura B, Aydemir U, Herschbach P, Duhmke E: Quality of life (QoL) as predictive mediator variable for survival in patients with intracerebral neoplasma during radiotherapy. Onkologie 2003, 26: 38–43. 10.1159/000069862PubMedCrossRef Sehlen S, Lenk M, Hollenhorst H, Schymura B, Aydemir U, Herschbach P, Duhmke E: Quality of life (QoL) as predictive mediator variable for survival in patients with intracerebral neoplasma during radiotherapy. Onkologie 2003, 26: 38–43. 10.1159/000069862PubMedCrossRef

go back to reference Collette L, Andel GA, Bottomley A, Oosterhof G, Albrecht W, Rrijke TM: Is baseline quality of life useful for predicting survival with hormone-Refractory prostate cancer? A pooled Analysis of three studies of the European organization for research and treatment of cancer genitourinary Group. J Clin Oncol 2004, 22: 3877–3885. 10.1200/JCO.2004.07.089PubMedCrossRef Collette L, Andel GA, Bottomley A, Oosterhof G, Albrecht W, Rrijke TM: Is baseline quality of life useful for predicting survival with hormone-Refractory prostate cancer? A pooled Analysis of three studies of the European organization for research and treatment of cancer genitourinary Group. J Clin Oncol 2004, 22: 3877–3885. 10.1200/JCO.2004.07.089PubMedCrossRef

go back to reference Monk BJ, Huang HQ, Cella D, Long HJ, Gynecologic oncology Group study: Quality of life outcome from a randomized phase III trial of cisplatin with or without topotecan in advanced carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol 2005, 23: 4617–4625. 10.1200/JCO.2005.10.522PubMedCrossRef Monk BJ, Huang HQ, Cella D, Long HJ, Gynecologic oncology Group study: Quality of life outcome from a randomized phase III trial of cisplatin with or without topotecan in advanced carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol 2005, 23: 4617–4625. 10.1200/JCO.2005.10.522PubMedCrossRef

go back to reference Brown PD, Maurer MJ, Rummans TA, Pollock BE, Ballman KV, Sloan JA, Boeve BF, Arusell RM, Clark MM, Buckner JC: A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival. Neurosurgery 2005, 57: 495–504. 10.1227/01.NEU.0000170562.25335.C7PubMedCrossRef Brown PD, Maurer MJ, Rummans TA, Pollock BE, Ballman KV, Sloan JA, Boeve BF, Arusell RM, Clark MM, Buckner JC: A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival. Neurosurgery 2005, 57: 495–504. 10.1227/01.NEU.0000170562.25335.C7PubMedCrossRef

go back to reference Brown PD, Ballman KV, Rummans TA, Maurer MJ, Sloan JA, Boeve BF, Gupta L, Tang-Wai DF, Arusell RM, Clark MM, Buckner JC: Prospective study of quality of life adults with newly diagnosed high-grade gliomas. J Neurooncol 2006, 76: 283–291. 10.1007/s11060-005-7020-9PubMedCrossRef Brown PD, Ballman KV, Rummans TA, Maurer MJ, Sloan JA, Boeve BF, Gupta L, Tang-Wai DF, Arusell RM, Clark MM, Buckner JC: Prospective study of quality of life adults with newly diagnosed high-grade gliomas. J Neurooncol 2006, 76: 283–291. 10.1007/s11060-005-7020-9PubMedCrossRef

go back to reference Yeo W, Mo FK, Koh J, Chan AT, Leung T, Hui P, Chan L, Tang A, Lee JJ, Mok TS, Lai PB, Johnson PJ, Zee B: Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma. Ann Oncol 2006, 17: 1083–1089. 10.1093/annonc/mdl065PubMedCrossRef Yeo W, Mo FK, Koh J, Chan AT, Leung T, Hui P, Chan L, Tang A, Lee JJ, Mok TS, Lai PB, Johnson PJ, Zee B: Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma. Ann Oncol 2006, 17: 1083–1089. 10.1093/annonc/mdl065PubMedCrossRef

go back to reference Lis CG, Gupta D, Grutsch JF: Patient satisfaction with quality of life as a predictor of survival in pancreatic cancer. Int J Gastrointest Cancer 2006, 37: 35–44. 10.1385/IJGC:37:1:35PubMedCrossRef Lis CG, Gupta D, Grutsch JF: Patient satisfaction with quality of life as a predictor of survival in pancreatic cancer. Int J Gastrointest Cancer 2006, 37: 35–44. 10.1385/IJGC:37:1:35PubMedCrossRef

go back to reference Dubois D, Dhawan R, velde H, Esseltine D, Gupta S, Viala M, Loge C: Descriptive and prognostic value of patient-reported outcomes: the bortezomib experience in relapsed and refractory multiple myeloma. J Clin Oncol 2006, 24: 976–982. 10.1200/JCO.2005.04.0824PubMedCrossRef Dubois D, Dhawan R, velde H, Esseltine D, Gupta S, Viala M, Loge C: Descriptive and prognostic value of patient-reported outcomes: the bortezomib experience in relapsed and refractory multiple myeloma. J Clin Oncol 2006, 24: 976–982. 10.1200/JCO.2005.04.0824PubMedCrossRef

go back to reference Sullivan PW, Nelson JB, Mulani PM, Sleep D: Quality of life as potential predictor morbidity and mortality in patients with metastastic hormone-refractory prostate cancer. Qual Life Res 2006, 15: 1297–1306. 10.1007/s11136-006-0003-2PubMedCrossRef Sullivan PW, Nelson JB, Mulani PM, Sleep D: Quality of life as potential predictor morbidity and mortality in patients with metastastic hormone-refractory prostate cancer. Qual Life Res 2006, 15: 1297–1306. 10.1007/s11136-006-0003-2PubMedCrossRef

go back to reference Mauer ME, Taphoorn MJ, Bottomley A, Coens C, Efficace F, Sanson M, Brandes AA, Rijt CC, Bernsen HJ, Frénay M, Tijssen CC, Lacombe D, Bent MJ, EORTC Brain Cancer Group: Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC brain cancer group study. J Clin Oncol 2007, 25: 5731–5737. 10.1200/JCO.2007.11.1476PubMedCrossRef Mauer ME, Taphoorn MJ, Bottomley A, Coens C, Efficace F, Sanson M, Brandes AA, Rijt CC, Bernsen HJ, Frénay M, Tijssen CC, Lacombe D, Bent MJ, EORTC Brain Cancer Group: Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC brain cancer group study. J Clin Oncol 2007, 25: 5731–5737. 10.1200/JCO.2007.11.1476PubMedCrossRef

go back to reference Mauer M, Stupp R, Taphoorn MJ, Coens C, Osoba D, Marosi C, Wong R, Witte O, Caimcross JG, Efficace F, Mirimarnoff RO, Forsyth P, Bent MJ, Weller M, Bottomley A: The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group study. Br J Cancer 2007, 97: 302–307. 10.1038/sj.bjc.6603876PubMedPubMedCentralCrossRef Mauer M, Stupp R, Taphoorn MJ, Coens C, Osoba D, Marosi C, Wong R, Witte O, Caimcross JG, Efficace F, Mirimarnoff RO, Forsyth P, Bent MJ, Weller M, Bottomley A: The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group study. Br J Cancer 2007, 97: 302–307. 10.1038/sj.bjc.6603876PubMedPubMedCentralCrossRef

go back to reference Viala M, Bhakar AL, de la Loge C, Velde H, Esseltine D, Chang M, Dhawan R, Dubois D: Patient-reported outcomes helped predict survival in multiple myeloma using partial least squares analysis. J Clin Epidemiol 2007, 60: 670–679. 10.1016/j.jclinepi.2006.10.006PubMedCrossRef Viala M, Bhakar AL, de la Loge C, Velde H, Esseltine D, Chang M, Dhawan R, Dubois D: Patient-reported outcomes helped predict survival in multiple myeloma using partial least squares analysis. J Clin Epidemiol 2007, 60: 670–679. 10.1016/j.jclinepi.2006.10.006PubMedCrossRef

go back to reference Bonnetain F, Paoletti X, Collette S, Doffoel M, Bouché O, Raoul JL, Rougier P, Masskouri F, Barbare JC, Bedenne L: Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: results from two French clinical trials. Qual Life Res 2008, 17: 831–843. 10.1007/s11136-008-9365-yPubMedCrossRef Bonnetain F, Paoletti X, Collette S, Doffoel M, Bouché O, Raoul JL, Rougier P, Masskouri F, Barbare JC, Bedenne L: Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: results from two French clinical trials. Qual Life Res 2008, 17: 831–843. 10.1007/s11136-008-9365-yPubMedCrossRef

go back to reference Carey MS, Bacon M, Tu D, Butler L, Bezjak A, Stuart GC: The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer. Gynecol Oncol 2008, 108: 100–105. 10.1016/j.ygyno.2007.08.088PubMedCrossRef Carey MS, Bacon M, Tu D, Butler L, Bezjak A, Stuart GC: The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer. Gynecol Oncol 2008, 108: 100–105. 10.1016/j.ygyno.2007.08.088PubMedCrossRef

go back to reference Gupta D, Grutsch JF, Lis CG: Patient satisfaction with quality of life as a prognostic indicator in ovarian cancer patients treated in an integrative treatment setting. J Soc Integr Oncol 2008, 6: 98–104.PubMed Gupta D, Grutsch JF, Lis CG: Patient satisfaction with quality of life as a prognostic indicator in ovarian cancer patients treated in an integrative treatment setting. J Soc Integr Oncol 2008, 6: 98–104.PubMed

go back to reference Robinson DW, Eisenberg DF, Cella D, Zhao N, de Boer C, De Witte M: The prognostic significance of patient-reported outcomes in pancreatic cancer cachexia. J Support Oncol 2008, 6: 283–290.PubMed Robinson DW, Eisenberg DF, Cella D, Zhao N, de Boer C, De Witte M: The prognostic significance of patient-reported outcomes in pancreatic cancer cachexia. J Support Oncol 2008, 6: 283–290.PubMed

go back to reference Strasser-Weippl K, Ludwig H: Psychosocial QOL is an independent predictor of overall survival in newly diagnosed patients with multiple myeloma. Eur J Haematol 2008, 81: 374–379.PubMed Strasser-Weippl K, Ludwig H: Psychosocial QOL is an independent predictor of overall survival in newly diagnosed patients with multiple myeloma. Eur J Haematol 2008, 81: 374–379.PubMed

go back to reference Gotay CC, Kawamoto CT, Bottomoley A, Efficace F: The prognostic significance of patient-reported outcomes in cancer clinical trials. J Clin Oncol 2008, 26: 1355–1363. 10.1200/JCO.2007.13.3439PubMedCrossRef Gotay CC, Kawamoto CT, Bottomoley A, Efficace F: The prognostic significance of patient-reported outcomes in cancer clinical trials. J Clin Oncol 2008, 26: 1355–1363. 10.1200/JCO.2007.13.3439PubMedCrossRef

go back to reference Van Steen K, Curran D, Kramer J, Molenberghs G, Van Verckem A, Bottomley A, Sylvester R: Multicollinearity in prognostic factor analyses using the EORTC QLQ-C30: identification and impact on model selection. Stat Med 2002, 21: 3865–3884. 10.1002/sim.1358PubMedCrossRef Van Steen K, Curran D, Kramer J, Molenberghs G, Van Verckem A, Bottomley A, Sylvester R: Multicollinearity in prognostic factor analyses using the EORTC QLQ-C30: identification and impact on model selection. Stat Med 2002, 21: 3865–3884. 10.1002/sim.1358PubMedCrossRef

go back to reference Herrmann E, Gerss J, Bierer S, Kopke T, Bolenz C, Hertle L, Wulfing C: Pre-treatment global quality of health predicts progression free survival in metastatic kidney cancer patients treated with sorafenib or sunitinib. J Cancer Res Clin Oncol 2009, 135: 61–67. 10.1007/s00432-008-0438-7PubMedCrossRef Herrmann E, Gerss J, Bierer S, Kopke T, Bolenz C, Hertle L, Wulfing C: Pre-treatment global quality of health predicts progression free survival in metastatic kidney cancer patients treated with sorafenib or sunitinib. J Cancer Res Clin Oncol 2009, 135: 61–67. 10.1007/s00432-008-0438-7PubMedCrossRef

go back to reference Spiegel D: Psychosocial aspects of breast cancer treatment. Semin Oncol 1997,24(Suppl 1):S36-S47. Spiegel D: Psychosocial aspects of breast cancer treatment. Semin Oncol 1997,24(Suppl 1):S36-S47.

go back to reference Gordon JS: Mind-body medicine and cancer. Hematol Oncol Clin North Am 2008, 22: 683–708. 10.1016/j.hoc.2008.04.010PubMedCrossRef Gordon JS: Mind-body medicine and cancer. Hematol Oncol Clin North Am 2008, 22: 683–708. 10.1016/j.hoc.2008.04.010PubMedCrossRef

go back to reference Littrell J: The mind-body connection: not just a theory anymore. Soc Work Health Care 2008, 46: 17–37. 10.1300/J010v46n04_02PubMedCrossRef Littrell J: The mind-body connection: not just a theory anymore. Soc Work Health Care 2008, 46: 17–37. 10.1300/J010v46n04_02PubMedCrossRef

go back to reference Jylhä M: What is self-rated health and why does it predict mortality? Towards a unified conceptual model. Soc Sci Med 2009, 69: 307–316. 10.1016/j.socscimed.2009.05.013PubMedCrossRef Jylhä M: What is self-rated health and why does it predict mortality? Towards a unified conceptual model. Soc Sci Med 2009, 69: 307–316. 10.1016/j.socscimed.2009.05.013PubMedCrossRef

go back to reference Harris AR, Bowley DM, Stannard A, Kurrimboccus S, Geh JI, Karandikar S: Socioeconomic deprivation adversely affects survival of patients with rectal cancer. Br J Surg 2009, 96: 763–768. 10.1002/bjs.6621PubMedCrossRef Harris AR, Bowley DM, Stannard A, Kurrimboccus S, Geh JI, Karandikar S: Socioeconomic deprivation adversely affects survival of patients with rectal cancer. Br J Surg 2009, 96: 763–768. 10.1002/bjs.6621PubMedCrossRef

go back to reference Braaten T, Weiderpass E, Lund E: Socioeconomic differences in cancer survival: the Norwegian Women and Cancer Study. BMC Public Health 2009, 9: 178. 10.1186/1471-2458-9-178PubMedPubMedCentralCrossRef Braaten T, Weiderpass E, Lund E: Socioeconomic differences in cancer survival: the Norwegian Women and Cancer Study. BMC Public Health 2009, 9: 178. 10.1186/1471-2458-9-178PubMedPubMedCentralCrossRef

go back to reference Kelsall HL, Baglietto L, Muller D, Haydon AM, English DR, Giles GG: The effect of socioeconomic status on survival from colorectal cancer in the Melbourne Collaborative Cohort Study. Soc Sci Med 2009, 68: 290–297. 10.1016/j.socscimed.2008.09.070PubMedCrossRef Kelsall HL, Baglietto L, Muller D, Haydon AM, English DR, Giles GG: The effect of socioeconomic status on survival from colorectal cancer in the Melbourne Collaborative Cohort Study. Soc Sci Med 2009, 68: 290–297. 10.1016/j.socscimed.2008.09.070PubMedCrossRef

go back to reference Byers TE, Wolf HJ, Bauer KR, Bolick-Aldrich S, Chen VW, Finch JL, Fulton JP, Schymura MJ, Shen T, Van Heest S, Yin X, Patterns of Care Study Group: The impact of socioeconomic status on survival after cancer in the United States: findings from the National Program of Cancer Registries Patterns of Care Study. Cancer 2008, 113: 582–591. 10.1002/cncr.23567PubMedCrossRef Byers TE, Wolf HJ, Bauer KR, Bolick-Aldrich S, Chen VW, Finch JL, Fulton JP, Schymura MJ, Shen T, Van Heest S, Yin X, Patterns of Care Study Group: The impact of socioeconomic status on survival after cancer in the United States: findings from the National Program of Cancer Registries Patterns of Care Study. Cancer 2008, 113: 582–591. 10.1002/cncr.23567PubMedCrossRef

go back to reference Ou SH, Zell JA, Ziogas A, Anton-Culver H: Low socioeconomic status is a poor prognostic factor for survival in stage I non-small cell lung cancer and is independent of surgical treatment, race, and marital status. Cancer 2008, 12: 2011–2020. 10.1002/cncr.23397CrossRef Ou SH, Zell JA, Ziogas A, Anton-Culver H: Low socioeconomic status is a poor prognostic factor for survival in stage I non-small cell lung cancer and is independent of surgical treatment, race, and marital status. Cancer 2008, 12: 2011–2020. 10.1002/cncr.23397CrossRef

go back to reference Gomez SL, O'Malley CD, Stroup A, Shema SJ, Satariano WA: Longitudinal, population-based study of racial/ethnic differences in colorectal cancer survival: impact of neighborhood socioeconomic status, treatment and comorbidity. BMC Cancer 2007, 7: 193. 10.1186/1471-2407-7-193PubMedPubMedCentralCrossRef Gomez SL, O'Malley CD, Stroup A, Shema SJ, Satariano WA: Longitudinal, population-based study of racial/ethnic differences in colorectal cancer survival: impact of neighborhood socioeconomic status, treatment and comorbidity. BMC Cancer 2007, 7: 193. 10.1186/1471-2407-7-193PubMedPubMedCentralCrossRef

go back to reference Shack LG, Rachet B, Brewster DH, Coleman MP: Socioeconomic inequalities in cancer survival in Scotland 1986–2000. Br J Cancer 2007, 97: 999–1004.PubMedPubMedCentral Shack LG, Rachet B, Brewster DH, Coleman MP: Socioeconomic inequalities in cancer survival in Scotland 1986–2000. Br J Cancer 2007, 97: 999–1004.PubMedPubMedCentral

go back to reference Dalton SO, Ross L, Düring M, Carlsen K, Mortensen PB, Lynch J, Johansen C: Influence of socioeconomic factors on survival after breast cancer--a nationwide cohort study of women diagnosed with breast cancer in Denmark 1983–1999. Int J Cancer 2007, 121: 1983–1999. 10.1002/ijc.22979CrossRef Dalton SO, Ross L, Düring M, Carlsen K, Mortensen PB, Lynch J, Johansen C: Influence of socioeconomic factors on survival after breast cancer--a nationwide cohort study of women diagnosed with breast cancer in Denmark 1983–1999. Int J Cancer 2007, 121: 1983–1999. 10.1002/ijc.22979CrossRef

go back to reference Du XL, Meyer TE, Franzini L: Meta-analysis of racial disparities in survival in association with socioeconomic status among men and women with colon cancer. Cancer 2007, 109: 2161–2170. 10.1002/cncr.22664PubMedCrossRef Du XL, Meyer TE, Franzini L: Meta-analysis of racial disparities in survival in association with socioeconomic status among men and women with colon cancer. Cancer 2007, 109: 2161–2170. 10.1002/cncr.22664PubMedCrossRef

go back to reference Ashing-Giwa KT, Lim JW: Examining the impact of socioeconomic status and socioecologic stress on physical and mental health quality of life among breast cancer survivors. Oncol Nurs Forum 2009, 36: 79–88. 10.1188/09.ONF.79-88PubMedCrossRef Ashing-Giwa KT, Lim JW: Examining the impact of socioeconomic status and socioecologic stress on physical and mental health quality of life among breast cancer survivors. Oncol Nurs Forum 2009, 36: 79–88. 10.1188/09.ONF.79-88PubMedCrossRef

go back to reference Demiral AN, Sen M, Demiral Y, Kinay M: The effect of socioeconomic factors on quality of life after treatment in patients with head and neck cancer. Int J Radiat Oncol Biol Phys 2008, 70: 23–27. 10.1016/j.ijrobp.2007.05.056PubMedCrossRef Demiral AN, Sen M, Demiral Y, Kinay M: The effect of socioeconomic factors on quality of life after treatment in patients with head and neck cancer. Int J Radiat Oncol Biol Phys 2008, 70: 23–27. 10.1016/j.ijrobp.2007.05.056PubMedCrossRef

go back to reference Bowen DJ, Alfano CM, McGregor BA, Kuniyuki A, Bernstein L, Meeske K, Baumgartner KB, Fetherolf J, Reeve BB, Smith AW, Ganz PA, McTiernan A, Barbash RB: Possible socioeconomic and ethnic disparities in quality of life in a cohort of breast cancer survivors. Breast Cancer Res Treat 2007, 106: 85–95. 10.1007/s10549-006-9479-2PubMedPubMedCentralCrossRef Bowen DJ, Alfano CM, McGregor BA, Kuniyuki A, Bernstein L, Meeske K, Baumgartner KB, Fetherolf J, Reeve BB, Smith AW, Ganz PA, McTiernan A, Barbash RB: Possible socioeconomic and ethnic disparities in quality of life in a cohort of breast cancer survivors. Breast Cancer Res Treat 2007, 106: 85–95. 10.1007/s10549-006-9479-2PubMedPubMedCentralCrossRef

go back to reference Montazeri A, Hole DJ, Milroy R, McEwen J, Gillis CR: Quality of life in lung cancer patients: does socioeconomic status matter? Health Qual Life Outcomes 2003, 1: 19. 10.1186/1477-7525-1-19PubMedPubMedCentralCrossRef Montazeri A, Hole DJ, Milroy R, McEwen J, Gillis CR: Quality of life in lung cancer patients: does socioeconomic status matter? Health Qual Life Outcomes 2003, 1: 19. 10.1186/1477-7525-1-19PubMedPubMedCentralCrossRef

go back to reference Petticrew M, Bell R, Hunter D: Influence of psychological coping on survival and recurrence in people with cancer: systematic review. BMJ 2002, 325: 1066. 10.1136/bmj.325.7372.1066PubMedPubMedCentralCrossRef Petticrew M, Bell R, Hunter D: Influence of psychological coping on survival and recurrence in people with cancer: systematic review. BMJ 2002, 325: 1066. 10.1136/bmj.325.7372.1066PubMedPubMedCentralCrossRef

go back to reference Falagas ME, Zarkadoulia EA, Ioannidou EN, Peppas G, Christodoulou C, Rafailidis PI: The effect of psychosocial factors on breast cancer outcome: a systematic review. Breast Cancer Res 2007, 9: R44. 10.1186/bcr1744PubMedPubMedCentralCrossRef Falagas ME, Zarkadoulia EA, Ioannidou EN, Peppas G, Christodoulou C, Rafailidis PI: The effect of psychosocial factors on breast cancer outcome: a systematic review. Breast Cancer Res 2007, 9: R44. 10.1186/bcr1744PubMedPubMedCentralCrossRef

go back to reference Chida Y, Hamer M, Wardle j, Steptoe A: Do stress-related psychosocial factors contribute to cancer incidence and survival? Nat Clin Pract Oncol 2008, 5: 466–475. 10.1038/ncponc1134PubMedCrossRef Chida Y, Hamer M, Wardle j, Steptoe A: Do stress-related psychosocial factors contribute to cancer incidence and survival? Nat Clin Pract Oncol 2008, 5: 466–475. 10.1038/ncponc1134PubMedCrossRef

go back to reference Mauer ME, Bottomley A, Coens C: Statistical methodology is crucial in prognostic factor analysis of health-related quality of life. Qual Life Res 2008, 17: 1043–1044. 10.1007/s11136-008-9357-yPubMedCrossRef Mauer ME, Bottomley A, Coens C: Statistical methodology is crucial in prognostic factor analysis of health-related quality of life. Qual Life Res 2008, 17: 1043–1044. 10.1007/s11136-008-9357-yPubMedCrossRef

go back to reference Mauer ME, Bottomley A, Coens C, Gotay C: Prognostic factor analysis of health-related quality of life data in cancer: a statistical methodological evaluation. Expert Rev Pharmacoecon Outcomes Res 2008, 8: 179–196. 10.1586/14737167.8.2.179PubMedCrossRef Mauer ME, Bottomley A, Coens C, Gotay C: Prognostic factor analysis of health-related quality of life data in cancer: a statistical methodological evaluation. Expert Rev Pharmacoecon Outcomes Res 2008, 8: 179–196. 10.1586/14737167.8.2.179PubMedCrossRef

go back to reference Bottomley A, Efficace F: Predicting survival in advanced cancer patients: is it possible with patient-reported health status data? Ann Oncol 2006, 17: 1037–1038. 10.1093/annonc/mdl123PubMedCrossRef Bottomley A, Efficace F: Predicting survival in advanced cancer patients: is it possible with patient-reported health status data? Ann Oncol 2006, 17: 1037–1038. 10.1093/annonc/mdl123PubMedCrossRef